Azacitidine
DrugBank ID: DB00928
Summary
| Metric | Value |
|---|---|
| Total Predictions | 51 |
| KG+DL (Dual Validated) | 16 |
| DL Only | 34 |
| KG Only | 1 |
Predictions
| Indication | Score | Source |
|---|---|---|
| acute myeloid leukemia with t(8;21)(q22;q22) translocation | 0.9881 | KG+DL |
| acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) | 0.9874 | KG+DL |
| acute myeloid leukemia with CEBPA somatic mutations | 0.9871 | KG+DL |
| bulbar polio | 0.9859 | DL |
| refractory cytopenia of childhood | 0.9820 | DL |
| unclassified myelodysplastic syndrome | 0.9810 | DL |
| partial deletion of the long arm of chromosome 5 | 0.9788 | DL |
| aregenerative anemia | 0.9788 | DL |
| severe congenital hypochromic anemia with ringed sideroblasts | 0.9756 | DL |
| 5q35 microduplication syndrome | 0.9748 | DL |
| myelodysplastic syndrome | 0.9726 | KG+DL |
| neuralgic amyotrophy | 0.9620 | DL |
| amyotrophic neuralgia | 0.9587 | DL |
| therapy related acute myeloid leukemia and myelodysplastic syndrome | 0.9460 | KG+DL |
| acute myeloid leukemia with t(8;16)(p11;p13) translocation | 0.9404 | KG+DL |
| familial thrombocytosis | 0.9309 | DL |
| acute myeloid leukemia with minimal differentiation | 0.9298 | KG+DL |
| acute myeloid leukemia with t(9;11)(p22;q23) | 0.9294 | KG+DL |
| acute myeloid leukemia with t(6;9)(p23;q34) | 0.9245 | KG+DL |
| inherited acute myeloid leukemia | 0.9226 | KG+DL |
| reactive thrombocytosis | 0.9210 | DL |
| upper aerodigestive tract neoplasm | 0.9124 | DL |
| chronic myelogenous leukemia, BCR-ABL1 positive | 0.9097 | DL |
| acute myeloid leukemia with NPM1 somatic mutations | 0.8968 | KG+DL |
| unclassified acute myeloid leukemia | 0.8834 | KG+DL |
| acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor | 0.8650 | KG+DL |
| acute myeloblastic leukemia with maturation | 0.8501 | KG+DL |
| inverse Klippel-Trenaunay syndrome | 0.8499 | DL |
| myeloid leukemia | 0.8457 | KG+DL |
| myelodysplastic/myeloproliferative disease | 0.8422 | DL |
| acute myeloblastic leukemia without maturation | 0.8232 | KG+DL |
| refractory hematologic cancer | 0.8170 | DL |
| thrombocythemia | 0.8112 | DL |
| fibromatosis, gingival | 0.7819 | DL |
| bilineal acute myeloid leukemia | 0.7796 | DL |
| acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent | 0.7794 | DL |
| acute myeloid leukemia and myelodysplastic syndromes related to radiation | 0.7794 | DL |
| Richter syndrome | 0.7763 | DL |
| inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia | 0.7688 | DL |
| head and neck cancer | 0.7514 | DL |
| metastatic neoplasm | 0.7391 | DL |
| malignant spiradenoma | 0.7389 | DL |
| ovarioleukodystrophy | 0.7382 | DL |
| acute panmyelosis with myelofibrosis | 0.7380 | DL |
| lung hilum carcinoma | 0.7373 | DL |
| lung benign neoplasm | 0.7288 | DL |
| metastatic melanoma | 0.7212 | DL |
| hamartoma of lung | 0.7146 | DL |
| gastric linitis plastica | 0.7144 | DL |
| non-cutaneous melanoma | 0.7115 | DL |
Showing top 50 of 51 predictions.
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.